CS logo
small CS logo
Institut de Recherche en Cancerologie de Montpellier

Montpellier, France
Hospital in Montpellier
124 Av. des Apothicaires, 34090 Montpellier

About Institut de Recherche en Cancerologie de Montpellier


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Institut de Recherche en Cancerologie de Montpellier


During the past decade, Institut de Recherche en Cancerologie de Montpellier conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de Recherche en Cancerologie de Montpellier" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Institut de Recherche en Cancerologie de Montpellier


According to Clinical.Site data, the most researched conditions in "Institut de Recherche en Cancerologie de Montpellier" are "Gastrointestinal Tract Malignancies" (1 trials) and "Glioblastoma Multiforme, Adult" (1 trials). Many other conditions were trialed in "Institut de Recherche en Cancerologie de Montpellier" in a lesser frequency.

Clinical Trials Intervention Types at Institut de Recherche en Cancerologie de Montpellier


Most popular intervention types in "Institut de Recherche en Cancerologie de Montpellier" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Berubicin" (1 trials), "Domvanalimab" (1 trials), "Fluorouracil" (1 trials), "Leucovorin" (1 trials) and "Lomustine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institut de Recherche en Cancerologie de Montpellier


The vast majority of trials in "Institut de Recherche en Cancerologie de Montpellier" are 2 trials for "All" genders.

Clinical Trials Status at Institut de Recherche en Cancerologie de Montpellier


Currently, there are NaN active trials in "Institut de Recherche en Cancerologie de Montpellier". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institut de Recherche en Cancerologie de Montpellier, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut de Recherche en Cancerologie de Montpellier, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".